New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte announced that new data demonstrating the prognostic utility of the Decipher® Prostate genomic classifier were published in JAMA Oncology.

Click to view original post